News

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016 [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous ...
Nature15h
How Ebola and Marburg viruses battle the immune system
The filoviruses Ebola and Marburg use several different and effective mechanisms to both evade and battle the immune system. This Review explores recent findings in the filovirus–host-defence ...
WCBE6h
Texas is relying on FEMA. State leaders said it should be cut
The governor and top emergency official in Texas are both members of a council advising the Trump administration on options ...